Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03638999 · ClinicalTrials.gov registry record · Early Phase 1
NSAIDs Stent Study
A Early Phase 1 study of Kidney Stone and Ureteral Stent Placement, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT03638999: Recruiting Early Phase 1 study of Kidney Stone and Ureteral Stent Placement, sponsored by Washington University School of Medicine.
NCT03638999 is a Early Phase 1 study of Kidney Stone and Ureteral Stent Placement that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 36 participants, below the 192-participant average among 28 other Kidney Stone trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03638999, a Early Phase 1 study of Kidney Stone and Ureteral Stent Placement, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to (1) evaluate the effect of Ketorolac on inflammatory response and its impact on stent related symptoms in patients undergoing stent placement procedure and (2) assess feasibility of recruitment, randomization, assessment procedures and implementation of the study intervention.
Primary Outcome
The Analog Pain Scale is a patient reported scale from 0-10 that will be administered after standard surgical procedure of ureteroscopy with or without laser lithotripsy and/or stone extraction). The Analog Pain Scale uses 0 (zero) to describe no pain and 10 will reference worst pain.
Conditions Studied
Interventions
- DRUG Normal saline
- DRUG Ketorolac Trometamol 30Mg/1mL Injection
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2027-10 |
| Phase | Early Phase 1 |
What NCT03638999 shows while recruiting
NCT03638999 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 192-participant average among 28 other Kidney Stone trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Kidney Stone appearing as the primary indexed condition, and to 2 interventions - of which Normal saline is the first listed.
NCT03638999 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03638999 about?
NCT03638999 is a clinical study titled "NSAIDs Stent Study". This is a pilot study to (1) evaluate the effect of Ketorolac on inflammatory response and its impact on stent related symptoms in patients undergoing stent placement procedure and (2) assess feasibility of recruitment, randomization, assessment procedures and implementation of the study interventio...
What is the current status of trial NCT03638999?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 36 participants. The study started on 2018-07-31. Estimated completion is 2027-10.
What conditions does trial NCT03638999 study?
This clinical trial studies the following conditions: Kidney Stone, Ureteral Stent Placement.
What interventions are being tested in trial NCT03638999?
The interventions under investigation include: Normal saline (DRUG), Ketorolac Trometamol 30Mg/1mL Injection (DRUG).
Who is sponsoring clinical trial NCT03638999?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03638999 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03638999's enrollment target sits among peer trials
36 21st of 28 higher than 8 of 28 other Kidney Stone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
RECRUITING · NA
-
Access Sheath and Stent Trial
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI